Avidity Biosciences, Inc. (RNA)
71.42
+0.12
(+0.18%)
USD |
NASDAQ |
Dec 10, 11:14
Avidity Biosciences Profit Margin (Quarterly): -1.40K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Novartis AG | 28.26% |
| Eli Lilly & Co. | 31.72% |
| Dyne Therapeutics, Inc. | -- |
| Astria Therapeutics, Inc. | -4.48K% |
| Intellia Therapeutics, Inc. | -735.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.47% |
| Return on Assets | -33.66% |
| Return on Invested Capital | -37.09% |
| Gross Profit Margin (Quarterly) | 91.54% |
| Operating Margin (Quarterly) | -1.51K% |
| Return on Net Operating Assets | -1.19K% |